It has been shown that PD-L1 induction can result from cell stress, acting as a protective measure [93,94], suggesting that the MSCs may be acting to reduce cancer cell stress in response to the EGFR inhibitor, and further emphasising the importance of including key cellular components of the TME in in vitro studies. The gene discussed is EGFR; the disease is cancer.